Research study Program year 2019 Source: CMS Open Payments

An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A

ClinicalTrials.gov NCT02172950

Research payments

$85,660

27 payments

Through program year 2019, $85,660 in research payments was reported against An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A, across 27 payments, paid by CSL Behring.

Paid by: CSL Behring
ClinicalTrials.gov: NCT02172950

By program year

1 row

Year	Kind	Amount	Payments
2019	Research	$85,660	27

Breakdown

Who paid Research payments · program year 2019

CSL Behring $85,660 27 payments

Who received the money Research payments · program year 2019

Bloodcenter Of Wisconsin Organisation paid for research $32,462 11 payments
University Of Miami Dba Umsponsored Programs Organisation paid for research $19,020 5 payments
Regents Of The University Of Colorado Organisation paid for research $10,116 4 payments
Connecticut Childrens Medical Center Teaching hospital · CT $7,750 1 payment
Rush University Medical Center Teaching hospital · IL $7,263 1 payment
The University Of Texas Health Science Center At Houston Organisation paid for research $4,031 1 payment
Tulane Medical Center Teaching hospital · LA $1,777 1 payment
Alliance For Childhood Diseases Dba Hemophilia Treatment Center Of Nevada Organisation paid for research $1,741 2 payments
Regents of the University of California San Diego Organisation paid for research $1,500 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.